Selective anticancer activity of imidazolium salts in prostate cancer cells via ROS-mediated mechanisms.
- DOI
- 10.1016/j.bioorg.2026.110264
- Published
- 2026 Oct 5
- Container
- Bioorganic chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bioorg.2026.110264,
title = {Selective anticancer activity of imidazolium salts in prostate cancer cells via ROS-mediated mechanisms.},
author = {Schrekker CML and Barra T and Vieira MO and Liguori F and Soriente A and Diel LF and Pereira ILG and Webber R and da Silva Bittencourt L and Bento FM and Ambrosio L and Lamers ML and Schrekker HS and Raucci MG},
year = {2026},
journal = {Bioorganic chemistry},
doi = {10.1016/j.bioorg.2026.110264},
url = {https://doi.org/10.1016/j.bioorg.2026.110264}
}RIS
TY - JOUR TI - Selective anticancer activity of imidazolium salts in prostate cancer cells via ROS-mediated mechanisms. AU - Schrekker CML AU - Barra T AU - Vieira MO AU - Liguori F AU - Soriente A AU - Diel LF AU - Pereira ILG AU - Webber R AU - da Silva Bittencourt L AU - Bento FM AU - Ambrosio L AU - Lamers ML AU - Schrekker HS AU - Raucci MG PY - 2026 JO - Bioorganic chemistry DO - 10.1016/j.bioorg.2026.110264 UR - https://doi.org/10.1016/j.bioorg.2026.110264 ER -
APA
CML, S., T, B., MO, V., F, L., A, S., LF, D., ILG, P., R, W., L, D. S. B., FM, B., L, A., ML, L., HS, S., & MG, R. (2026). Selective anticancer activity of imidazolium salts in prostate cancer cells via ROS-mediated mechanisms.. Bioorganic chemistry. https://doi.org/10.1016/j.bioorg.2026.110264
Source records
- pubmed · retrieved 2026-09-27T09:09:47.124Z